Department of Neurosurgery, University Hospital of Saint-Etienne, France.
Department of Neurosurgery, University Hospital of Saint-Etienne, France.
Neurochirurgie. 2024 Nov;70(6):101591. doi: 10.1016/j.neuchi.2024.101591. Epub 2024 Sep 10.
The aim of this study was to assess the capability of the Unruptured Intracranial Aneurysm Treatment Score (UIATS) to discriminate unruptured intracranial aneurysms (UIAs) at high risk for subarachnoid hemorrhage (aSAH).
During the period from January 2012 to December 2022, we included all consecutive adult patients admitted to our institution for an aSAH caused by the rupture of a saccular IA. The patient-related, aneurysm-related and treatment-related risk factors considered by UIATS were retrieved from medical records. After UIATS calculation for all ruptured IAs in the cohort, patients were categorized as "true positives (TP)" if UIATS would have (appropriately) oriented the management toward treatment, whereas patients for whom the UIATS would have (inappropriately) recommended observation were categorized as "false negatives (FN)". Patients for whom UIATS was inconclusive were categorized as "undetermined (UND)". Sensitivity of the UIATS (Se ) was calculated by using the following formula: TP/(TP + FN).
A total of 346 patients (253 women, 73%; mean age = 56 ± 1.45 years) were incorporated into the final analysis. There were 140 T P (40%), 79 F N (23%) and 127 UND (37%), leading to a Se of 63.9% (CI 58.3-69.5). Cumulatively, the UIATS failed to provide an appropriate recommendation in 60% of the entire cohort.
By retrospectively applying the UIATS in a cohort of ruptured IAs, our study emphasizes how vulnerable the UIATS can be. Even if the UIATS suggests conservative management, clinicians should inform patients that there is still a small risk of rupture.
本研究旨在评估未破裂颅内动脉瘤治疗评分(UIATS)区分蛛网膜下腔出血(aSAH)高危未破裂颅内动脉瘤(UIAs)的能力。
在 2012 年 1 月至 2022 年 12 月期间,我们纳入了所有因囊状颅内动脉瘤破裂导致蛛网膜下腔出血而入院的连续成年患者。从病历中检索了 UIATS 考虑的患者相关、动脉瘤相关和治疗相关危险因素。在对队列中的所有破裂性颅内动脉瘤进行 UIATS 计算后,如果 UIATS 会(适当)指导治疗管理,则将患者归类为“真阳性(TP)”,否则将归类为“假阴性(FN)”。如果 UIATS 不确定,则将患者归类为“不确定(UND)”。UIATS 的敏感性(Se)通过以下公式计算:TP/(TP+FN)。
共纳入 346 例患者(253 例女性,73%;平均年龄 56±1.45 岁)进行最终分析。其中 140 例 TP(40%)、79 例 FN(23%)和 127 例 UND(37%),Se 为 63.9%(CI 58.3-69.5)。累积来看,UIATS 在整个队列的 60%的情况下未能提供适当的建议。
通过回顾性地将 UIATS 应用于破裂性颅内动脉瘤队列,我们的研究强调了 UIATS 可能存在的脆弱性。即使 UIATS 建议保守治疗,临床医生也应告知患者仍存在破裂的小风险。